Australia's Nuheara climbs on positive trial results for hearing device
01/02/2022 04:26
** Shares of the audio-wearables maker NUH.AX rise as much
as 6.3% to A$0.017, their highest level since Jan 24
** Nuheara says it has successfully concluded its hearing
aid clinical trial with the final report received from National
Acoustic Laboratories urn:newsml:reuters.com:*:nASX6m4q7
** Adds the trial successfully validated benefit of NUH's
self-fitted hearing aids compared with unaided listening
** The study proved the effectiveness of co's Ear ID
self-fitted hearing aid devices by improving speech
understanding by 30% in noise - NUH
** As of last close, stock down 3% this year
(Reporting by Roushni Nair in Bengluru)
((Roushni.Nair@thomsonreuters.com;))